Two patients with arterial thromboembolism among 311 patients with adenocarcinoma of the pancreas

American Journal of the Medical Sciences

Volumn 324, Issue 6, 2002, Pages 335-338

  Schattner, Ami ^a   Klepfish, Avraham ^a   Huszar, Monica ^a   Shani, Adi ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Arterial cancer; Complications; Pancreatic cancer; Thromboembolism; Thrombophilia

Indexed keywords

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; EMBOLISM; ENDOCARDITIS; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; INTESTINE INFARCTION; MALE; MESENTERIC ARTERY; METASTASIS; NONBACTERIAL THROMBOTIC ENDOCARDITIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PATHOGENESIS; PREVALENCE; RETROSPECTIVE STUDY; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0036948904     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200212000-00009     Document Type: Article

References (28)

1. Gouin-Thibault I, Achkar A, Samama MM. The thrombophilic state in cancer patients. Acta Hematol 2001;106:33-42.
2. Thomas RH. Hypercoagulability syndromes. Arch Intern Med 2001;161:2433-9.
3. Hettiarachchi RJ, Lok J, Prins MH, et al. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis. Cancer 1998;83:180-5.
4. Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 2000;342:1953-8.
5. Sun NC, McAfee WM, Hum GJ, et al. Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol 1979;71:10-6.
6. Lopez JA, Ross RS, Fishbein MC, et al. Nonbacterial thrombotic endocarditis: a review. Am Heart J 1987;113:773-84.
7. Ojeda VJ, Frost F, Mastaglia FL. Non-bacterial thrombotic endocarditis associated with malignant disease: a clinicopathological study of 16 cases. Med J Aust 1985;142:629-31.
8. Sack GH Jr., Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977;56:1-37.
9. Polukhin E, Balla A, Chary K, et al. Microangiopathic hemolytic anemia as the first manifestation of lung adenocarcinoma. South Med J 2001;94:550-1.
10. Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Hemost 1999;25:173-82.
11. Edwards RL, Rickles FR, Moritz TE, et al. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 1987;88:596-602.
12. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992;11: 237-48.
13. Haim N, Lanir N, Hoffman R, et al. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism. Am J Med 2001; 110:91-6.
14. Asherson RA. Antiphospholipid antibodies, malignancies and paraproteins. J Autoimmun 2000;15:117-22.
15. Kakkar AK, De Ruvo N, Chinswangwatanakul V, et al. Extrinsic pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995;346:1004-5.
16. Zang Y, Deng Y, Luther T, et al. Tissue factor controls the balance of angiogenic and nonangiogenic of tumor cells in mice. J Clin Invest 1994;94:1320-7.
17. Contrino J, Hair G, Kreutzer DL, et al. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996;2:209-15.
18. Bevilacqua MP, Pober JS, Majeau GR, et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin-1. Proc Natl Acad Sci U S A 1986;83:4533-7.
19. Shoji M, Hancock WW, Abe K, et al. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 1998;152:399-411.
20. Carroll VA, Binder BR. The role of plasminogen activation system in cancer. Semin Thromb Hemost 1999;25:183-197.
21. Edoute Y, Haim N, Rinkevich D, et al. Cardiac valvular vegetations in cancer patients: a prospective echocardiographic study of 200 patients. Am J Med 1997;102:252-8.
22. Pathanjali Sharma PV, Babu SC, Shah PM, et al. Arterial thrombosis and embolism in malignancy. Cardiovasc Surg (Torino) 1985;26:479-83.
23. Holden A, Ferrar D. Spontaneous arterial thrombosis in association with pancreatic carcinoma: diagnosis and interventional management. Australas Radiol 1998;42:238-40.
24. Fernandez BB, Grove M, Carman TL. An unusual presentation of simultaneous bilateral popliteal artery embolism - a case report. Angiology 1998;49:573-6.
25. Cook Ma, Sanchez EJ, Lopez JJ Jr, et al. Acute myocardial infarction: a rare presentation of pancreatic carcinoma. J Clin Gastroenterol 1999;28:271-2.
26. Chaikof EL, Campbell BE, Smith RB 3rd. Paradoxical embolism and acute arterial occlusion: rare or unsuspected? J Vasc Surg 1994;20:377-84.
27. Mitsui T, Aoki Y, Nagata Y, et al. Patent foramen ovale complicated by paradoxical embolism and brain infarct in a patient with advanced ovarian cancer. Gynecol Oncol 2001;83:608-9.
28. Falanga A, Ofosu FA, Cortelazzo S, et al. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery. Br J Haematol 1993;85:745-50.